Inactive Instrument

Meda AB Stock

Stocks

End-of-day quote Nasdaq Stockholm
- ^SEK	-

21/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
16/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

21/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
16/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE
02/06/16	Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	RE
10/03/16	Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	RE
11/02/16	Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	RE
16/01/16	Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	RE
14/07/14	AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	RE
12/07/14	Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
12/07/14	Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
15/05/14	Banks vie for fees as Nordic deal scene ignites	RE
07/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
01/05/14	Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	RE

26/08/16	Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	BU
09/08/16	Meda : Delisting of Meda Aktiebolag (publ)	BU
06/08/16	MEDA: Notice to noteholders regarding change of control	BU
03/08/16	Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	BU
03/08/16	Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	BU

21/07/16	Mylan NV : La CE autorise Mylan à racheter Meda sous conditions
16/07/16	Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources
12/02/16	Cisco Systems : Wall Street ouvre en net recul
12/02/16	Wall Street ouvre en baisse, craintes sur la croissance mondiale
11/02/16	Meda : BOURSE-Meda s'envole de plus de 70% après son rachat par Mylan

Manager	Title	Age	Since
Lars Henrik Andreas Rejnus CEO	Chief Executive Officer	52	-
Mårten Österlund LAW	General Counsel	69	09/12/2014
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	64	01/01/2005

Director	Title	Age	Since
Colleen Ostrowski BRD	Director/Board Member	53	25/08/2016
Caroline Rebecca Louise Dixon BRD	Director/Board Member	58	25/08/2016
Lars Henrik Andreas Rejnus CHM	Chairman	52	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.71%	-7.04%	+59.44%	+110.68%	1,048B
JOHNSON & JOHNSON	-0.17%	-1.87%	+51.15%	+61.41%	640B
ABBVIE INC.	-0.75%	-3.37%	+23.14%	+73.66%	456B
ROCHE HOLDING AG	-1.46%	-4.50%	+37.43%	+38.41%	362B
NOVARTIS AG	-0.72%	-2.89%	+21.86%	+36.79%	295B
ASTRAZENECA PLC	-1.19%	-2.21%	+1.35%	+10.79%	255B
AMGEN INC.	-1.07%	-1.67%	+51.26%	+68.39%	236B
NOVO NORDISK A/S	+0.08%	-1.78%	-17.64%	-54.29%	204B
GILEAD SCIENCES, INC.	-2.32%	-0.54%	+29.11%	+88.64%	185B
Average	-0.89%	-0.72%	+28.57%	+48.28%	409.07B
Weighted average by Cap.	-0.77%	-1.92%	+37.99%	+64.63%